Skip to main content

An ethical, legal and practical perspective on the impact of a new regulatory framework for the scientific use of animals on research and innovation

Objective

Research with animals is considered necessary to obtain certain vital knowledge for advancing health research and innovation, but the harm such research may cause animals is ethically problematic. The European legislation regulating animal experimentation is based on the need to balance the two important interests at stake: advancing research and protecting animal welfare. The public sensitivity of the issue is evidenced by the exceptional participation in the legislative process leading to a revised European legislation. Directive 2010/63/EU (presently under transposition into Member State legislation) will bring about substantial changes compared to the previous directive dating from 1986. One of the main objectives of revising this legislation is to create a greater harmonization of the governance of the use of animals in scientific (including medical) research for the European research area. The transposition is being accompanied by European Commission initiatives to promote a common interpretation of the legislation. However, major determinants of how research in Europe will be affected remain largely uncharted, in that little is published about how legal, ethical and scientific decisions about research will be made and how regulation will influence these decisions. A multidisciplinary team of academic researchers from different EU Member States will use literature reviews, questionnaires, interviews, and focus groups to provide a deeper understanding of how the regulation interacts with research and innovation through the new common legal framework for animal experimentation in the EU. ANIMPACT will address the effectiveness of the new Directive and the current law in relation to other established norms in ethics, law, and scientific research, with focus on its interaction with ethics review and project licensing processes. The project will further consider the impact of the Directive on academic and commercial competitiveness as well as on animal welfare.

Call for proposal

FP7-HEALTH-2013-INNOVATION-1
See other projects for this call

Coordinator

INSTITUTO DE BIOLOGIA MOLECULAR E CELULAR-IBMC
Address
Rua Alfredo Allen 208
4200 135 Porto
Portugal

See on map

Activity type
Research Organisations
Administrative Contact
Claudia Ferreira (Dr.)
EU contribution
€ 136 975

Participants (5)

ISTITUTO SUPERIORE DI SANITA
Italy
EU contribution
€ 70 620
Address
Viale Regina Elena 299
00161 Roma

See on map

Activity type
Research Organisations
Administrative Contact
Rosa Martoccia (Dr.)
KOBENHAVNS UNIVERSITET
Denmark
EU contribution
€ 82 497
Address
Norregade 10
1165 Kobenhavn

See on map

Activity type
Higher or Secondary Education Establishments
Administrative Contact
Bjarne Friis Ploumark (Mr.)
LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN
Germany
EU contribution
€ 87 330
Address
Geschwister Scholl Platz 1
80539 Muenchen

See on map

Activity type
Higher or Secondary Education Establishments
Administrative Contact
Anna-Caroline Wöhr (Dr.)
THE UNIVERSITY OF SHEFFIELD
United Kingdom
EU contribution
€ 42 372
Address
Firth Court Western Bank
S10 2TN Sheffield

See on map

Activity type
Higher or Secondary Education Establishments
Administrative Contact
Joanne Watson (Mrs.)
UNIVERSITEIT MAASTRICHT
Netherlands
EU contribution
€ 78 761
Address
Minderbroedersberg 4
6200 MD Maastricht

See on map

Activity type
Higher or Secondary Education Establishments
Administrative Contact
Sabina Bulic (Mrs.)